Electromedical Technologies (Electromedical Technologies) LT-Debt-to-Total-Asset : 0.34 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Electromedical Technologies's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.34.

Electromedical Technologies's long-term debt to total assets ratio declined from Dec. 2022 (0.47) to Dec. 2023 (0.34). It may suggest that Electromedical Technologies is progressively becoming less dependent on debt to grow their business.

Electromedical Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Electromedical Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies LT-Debt-to-Total-Asset Chart

Electromedical Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

0.86

0.50

0.48

0.47

0.34

Electromedical Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial														0.47	0.10	0.15	0.32	0.34

Electromedical Technologies LT-Debt-to-Total-Asset Calculation

Electromedical Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.256	/	0.748
	=	0.34

Electromedical Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.256	/	0.748
	=	0.34

Electromedical Technologies (OTCPK:EMED) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Electromedical Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Electromedical Technologies (Electromedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260

Website

https://www.electromedtech.com

Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.

Executives

Hymers Iii R. Leslie	director	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson	director	PO BOX 41828, MESA AZ 41828
Donald J Steinberg	10 percent owner	3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson	director, officer: CEO, CFO	16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260